1. Functional exploration and drug prediction on programmed cell death-related biomarkers in lung adenocarcinoma
   Xugang Zhang et al, 2024, Heliyon CrossRef
2. IASLC grading system predicts distant metastases for resected lung adenocarcinoma
   Yuezhu Wang et al, 2024, Journal of Clinical Pathology CrossRef
3. m6A‐induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinoma
   Jiamei Wu et al, 2024, Journal of Cellular Physiology CrossRef
4. Construction of an immune-related gene prognostic model with experimental validation and analysis of immune cell infiltration in lung adenocarcinoma
   Jialei Yang et al, 2024, Oncology Letters CrossRef
5. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer
   Miguel A. Ortega et al, 2023, Journal of Personalized Medicine CrossRef
6. Long‑term control in a patient with lung adenocarcinoma, nonbacterial thrombotic endocarditis and multiple systemic emboli: A case report
   Takeshi Kawakami et al, 2024, Experimental and Therapeutic Medicine CrossRef
7. New molecular insights into ferroptosis in lung adenocarcinoma progression and pharmacological compounds for targeted therapy
   Wenhui Tian et al, 2024, The Journal of Gene Medicine CrossRef
8. Advances in combined neuroendocrine carcinoma of lung cancer
   Zesen Han et al, 2024, Pathology and Oncology Research CrossRef
9. Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study
   Yihui Ge et al, 2024, Cancer Medicine CrossRef
10. MECOM: a Bioinformatics and Experimentally Identified Marker for the Diagnosis and Prognosis of Lung Adenocarcinoma
    Anqi Li et al, 2024, Biomarkers in Medicine CrossRef
11. Identification of Biomarkers for Lung Adenocarcinoma With Qi Deficiency and Phlegm Dampness
    Jiabin Chen et al, 2024, The Clinical Respiratory Journal CrossRef
12. The diagnostic potential role of thioredoxin reductase and TXNRD1 in early lung adenocarcinoma: A cohort study
    Guanyu Jiang et al, 2024, Heliyon CrossRef
13. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques
    Dabao He et al, 2023, Frontiers in Immunology CrossRef